Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP
The approval expands Biocon’s capacities, with new large scale devices facility coming up to speed to serve growing needs of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Diabetes
Biocon collaborates with JDRF
JDRF provides financial support to accelerate breakthrough research in Type 1 Diabetes management
DDCR in research collaboration with RBPL
To explore new possibilities in diabetes research
Type 1 Diabetes may up epilepsy risk by three times: Study
Immune abnormalities, brain lesions, genetic factors and metabolic abnormalities are all potential causes for the link between…
Novo Nordisk names Sachin Tendulkar as brand ambassador of ‘Changing Diabetes’
The company has initiated the Changing Diabetes in Children, a programme designed to improve access to diabetes care for children…
NovaLead Pharma completes global phase I /II clinical trial for Galnobax
NovaLead Pharma announced a potential breakthrough in the treatment of diabetic foot ulcers (DFU)
Clinical trial shows superiority of one drug eluting stent over another in patients with diabetes
Prof Dr Upendra Kaul, presents data as a 'late breaking research' at the gathering of interventional cardiologists at TCT…
Lupin in agreement with Boehringer Ingelheim
Lupin to market Linagliptin for Boehringer Ingelheim under the brand name Ondero and Ondero Met in India
Lupin and Boehringer…
Improving blood sugar control could help prevent dementia in patients with type II diabetes: Study
Researchers identified all patients with type II diabetes and no known hospitalisation for dementia who were registered in the…
Study: Tresiba U200 delivers significantly lower rates of confirmed hypoglycaemia vs insulin…
More concentrated formulation means fewer injections, and consequently better patient compliance
New data presented at the 51st…